Artificial Insemination Market Research Report Information By Type (Intrauterine, Intracervical and Intratubal), End User (Hospitals & Clinics, Fertility Centre and Home-Based) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2032

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 MARKET STRUCTURE 14

2.4 ASSUMPTIONS & LIMITATIONS 15

3 RESEARCH METHODOLOGY

3.1 DATA MINING 16

3.2 SECONDARY RESEARCH 17

3.3 PRIMARY RESEARCH 18

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20

3.6.1 BOTTOM-UP APPROACH 21

3.6.2 TOP-DOWN APPROACH 21

3.7 DATA TRIANGULATION 22

3.8 VALIDATION 22

4 MARKET DYNAMICS

4.1 OVERVIEW 23

4.2 DRIVERS 24

4.2.1 GROWING RATE OF INFERTILITY IN THE WORLD 24

4.2.2 CHANGING LIFESTYLE AMONG POPULATION 24

4.2.3 RISE IN NHS FUNDED IN FERTILITY MARKET 24

4.3 RESTRAINTS 25

4.3.1 HIGH RISK OF CONCEIVING TWINS OR TRIPLETS AND OTHER COMPLICATIONS SUCH AS PREMATURE BIRTH OR MISCARRIAGE 25

4.4 OPPORTUNITIES 26

4.4.1 MEDICAL INSURANCE FOR THE COUPLES OF SAME SEXES 26

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 27

5.1.1 CONSULTING DOCTOR FOR EVALUATION 27

5.1.2 FERTILITY TESTING OF MALE & FEMALE 28

5.1.3 DIAGNOSIS 28

5.1.4 INSEMNINATION OF SPERM 28

5.2 PORTER’S FIVE FORCES MODEL 29

5.2.1 BARGAINING POWER OF SUPPLIERS 29

5.2.2 BARGAINING POWER OF BUYERS 29

5.2.3 THREAT OF NEW ENTRANTS 29

5.2.4 THREAT OF SUBSTITUTES 30

5.2.5 RIVALRY 30

5.3 COVID-19 IMPACT ANALYSIS 30

5.3.1 IMPACT ON GROWTH RATE 30

5.3.2 IMPACT ON MAJOR PLAYERS 30

5.3.3 IMPACT ON MAJOR REGIONS 30

6 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE

6.1 OVERVIEW 32

6.2 INTRAUTERINE 33

6.3 INTRACERVICAL 33

6.4 INTRATUBAL 34

7 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER

7.1 OVERVIEW 35

7.2 HOSPITALS & CLINICS 36

7.3 FERTILITY CENTRE 36

7.4 HOME-BASED 37

8 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION

8.1 OVERVIEW 38

8.2 AMERICAS 39

8.2.1 NORTH AMERICA 40

8.2.1.1 US 41

8.2.1.2 CANADA 42

8.2.2 LATIN AMERICA 43

8.3 EUROPE 44

8.3.1 WESTERN EUROPE 45

8.3.1.1 GERMANY 47

8.3.1.2 FRANCE 47

8.3.1.3 UK 48

8.3.1.4 ITALY 49

8.3.1.5 SPAIN 49

8.3.1.6 BELGIUM 50

8.3.1.7 SWEDEN 51

8.3.1.8 DENMARK 51

8.3.1.9 FINLAND 52

8.3.1.10 NORWAY 53

8.3.1.11 REST OF WESTERN EUROPE 53

8.3.2 EASTERN EUROPE 54

8.4 ASIA-PACIFIC 55

8.4.1 JAPAN 56

8.4.2 CHINA 57

8.4.3 INDIA 58

8.4.4 AUSTRALIA 58

8.4.5 SOUTH KOREA 59

8.4.6 REST OF ASIA-PACIFIC 60

8.5 MIDDLE EAST & AFRICA 61

8.5.1 MIDDLE EAST 62

8.5.2 AFRICA 63

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 64

9.2 COMPETITIVE BENCHMARKING 65

9.3 COMPETITOR DASHBOARD 66

9.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67

9.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67

9.6 KEY DEVELOPMENT ANALYSIS 68

9.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 68

9.7.1 PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68

9.7.2 EXPANSIONS 68

10 COMPANY PROFILES

10.1 VITROLIFE AB 69

10.1.1 COMPANY OVERVIEW 69

10.1.2 FINANCIAL OVERVIEW 70

10.1.3 PRODUCTS/SERVICES OFFERED 71

10.1.4 KEY DEVELOPMENTS 71

10.1.5 SWOT ANALYSIS 72

10.1.6 KEY STRATEGIES 72

10.2 GENEA LIMITED 73

10.2.1 COMPANY OVERVIEW 73

10.2.2 FINANCIAL OVERVIEW 73

10.2.3 PRODUCTS/SERVICES OFFERED 73

10.2.4 KEY DEVELOPMENTS 73

10.2.5 SWOT ANALYSIS 74

10.2.6 KEY STRATEGIES 74

10.3 RINOVUM WOMEN’S HEALTH, LLC 75

10.3.1 COMPANY OVERVIEW 75

10.3.2 FINANCIAL OVERVIEW 75

10.3.3 PRODUCTS/SERVICES OFFERED 75

10.3.4 KEY DEVELOPMENTS 75

10.3.5 SWOT ANALYSIS 76

10.3.6 KEY STRATEGIES 76

10.4 PRIDE ANGEL 77

10.4.1 COMPANY OVERVIEW 77

10.4.2 FINANCIAL OVERVIEW 77

10.4.3 PRODUCTS/SERVICES OFFERED 77

10.4.4 KEY DEVELOPMENTS 77

10.4.5 SWOT ANALYSIS 78

10.4.6 KEY STRATEGIES 78

10.5 HI-TECH SOLUTIONS 79

10.5.1 COMPANY OVERVIEW 79

10.5.2 FINANCIAL OVERVIEW 79

10.5.3 PRODUCTS/SERVICES OFFERED 79

10.5.4 KEY DEVELOPMENTS 79

10.5.5 SWOT ANALYSIS 80

10.5.6 KEY STRATEGIES 80

10.6 KITAZATO CORPORATION 81

10.6.1 COMPANY OVERVIEW 81

10.6.2 FINANCIAL OVERVIEW 81

10.6.3 PRODUCTS/SERVICES OFFERED 81

10.6.4 KEY DEVELOPMENTS 82

10.6.5 SWOT ANALYSIS 82

10.6.6 KEY STRATEGIES 82

10.7 FUJIFILM IRVINE SCIENTIFIC, INC. 83

10.7.1 COMPANY OVERVIEW 83

10.7.2 FINANCIAL OVERVIEW 83

10.7.3 PRODUCTS/SERVICES OFFERED 84

10.7.4 KEY DEVELOPMENTS 84

10.7.5 SWOT ANALYSIS 84

10.7.6 KEY STRATEGIES 85

10.8 ROCKET MEDICAL 86

10.8.1 COMPANY OVERVIEW 86

10.8.2 FINANCIAL OVERVIEW 86

10.8.3 PRODUCTS/SERVICES OFFERED 87

10.8.4 KEY DEVELOPMENTS 87

10.8.5 SWOT ANALYSIS 87

10.8.6 KEY STRATEGIES 87

11 APPENDIX

11.1 REFERENCES 88

11.2 RELATED REPORTS 89

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

TABLE 3 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 32

TABLE 4 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRAUTERINE, BY REGION, 2022-2030 (USD MILLION) 33

TABLE 5 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRACERVICAL, BY REGION, 2022-2030 (USD MILLION) 34

TABLE 6 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRATUBAL, BY REGION, 2022-2030 (USD MILLION) 34

TABLE 7 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 35

TABLE 8 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2022-2030 (USD MILLION) 36

TABLE 9 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR FERTILITY CENTRE, BY REGION, 2022-2030 (USD MILLION) 36

TABLE 10 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOME-BASED, BY REGION, 2022-2030 (USD MILLION) 37

TABLE 11 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 38

TABLE 12 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 39

TABLE 13 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 40

TABLE 14 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 40

TABLE 15 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 41

TABLE 16 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 41

TABLE 17 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 41

TABLE 18 US: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 41

TABLE 19 US: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 42

TABLE 20 CANADA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 42

TABLE 21 CANADA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 42

TABLE 22 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 43

TABLE 23 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 43

TABLE 24 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 44

TABLE 25 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 45

TABLE 26 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 45

TABLE 27 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 46

TABLE 28 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 46

TABLE 29 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 46

TABLE 30 GERMANY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 47

TABLE 31 GERMANY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 47

TABLE 32 FRANCE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 47

TABLE 33 FRANCE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 48

TABLE 34 UK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 48

TABLE 35 UK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 48

TABLE 36 ITALY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 49

TABLE 37 ITALY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 49

TABLE 38 SPAIN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 49

TABLE 39 SPAIN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 50

TABLE 40 BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 50

TABLE 41 BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 50

TABLE 42 SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 51

TABLE 43 SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 51

TABLE 44 DENMARK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 51

TABLE 45 DENMARK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 52

TABLE 46 FINLAND: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 52

TABLE 47 FINLAND: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 52

TABLE 48 NORWAY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 53

TABLE 49 NORWAY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 53

TABLE 50 REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 53

TABLE 51 REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 54

TABLE 52 EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 54

TABLE 53 EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 54

TABLE 54 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 55

TABLE 55 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 56

TABLE 56 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 56

TABLE 57 JAPAN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 56

TABLE 58 JAPAN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 57

TABLE 59 CHINA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 57

TABLE 60 CHINA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 57

TABLE 61 INDIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 58

TABLE 62 INDIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 58

TABLE 63 AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 58

TABLE 64 AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 59

TABLE 65 SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 59

TABLE 66 SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 59

TABLE 67 REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 60

TABLE 68 REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 60

TABLE 69 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 61

TABLE 70 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 62

TABLE 71 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 62

TABLE 72 MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 62

TABLE 73 MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 63

TABLE 74 AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 63

TABLE 75 AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 63

TABLE 76 MAJOR MANUFACTURERS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 65

TABLE 77 BENCHMARKING OF MAJOR COMPETITORS 65

TABLE 78 COMPETITOR DASHBOARD: GLOBAL ARTIFICIAL INSEMINATION MARKET 66

TABLE 79 MOST ACTIVE PLAYER IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67

TABLE 80 PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68

TABLE 81 EXPANSIONS 68

TABLE 82 VITROLIFE AB: PRODUCTS/SERVICES OFFERED 71

TABLE 83 VITROLIFE AB: KEY DEVELOPMENTS 71

TABLE 84 GENEA LIMITED: PRODUCTS/SERVICES OFFERED 73

TABLE 85 RINOVUM WOMEN’S HEALTH, LLC: PRODUCTS/SERVICES OFFERED 75

TABLE 86 RINOVUM WOMEN’S HEALTH, LLC: KEY DEVELOPMENTS 75

TABLE 87 PRIDE ANGEL: PRODUCTS/SERVICES OFFERED 77

TABLE 88 HI-TECH SOLUTIONS: PRODUCTS/SERVICES OFFERED 79

TABLE 89 KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 81

TABLE 90 KITAZATO CORPORATION: KEY DEVELOPMENTS 82

TABLE 91 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS/SERVICES OFFERED 84

TABLE 92 ROCKET MEDICAL: PRODUCTS/SERVICES OFFERED 87

13 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL ARTIFICIAL INSEMINATION MARKET 14

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ARTIFICIAL INSEMINATION MARKET 23

FIGURE 5 DRIVER IMPACT ANALYSIS 25

FIGURE 6 RESTRAINT IMPACT ANALYSIS 26

FIGURE 7 VALUE CHAIN: GLOBAL ARTIFICIAL INSEMINATION MARKET 27

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ARTIFICIAL INSEMINATION MARKET 29

FIGURE 9 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022 AND 2030 (USD MILLION) 32

FIGURE 10 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022 AND 2030 (USD MILLION) 35

FIGURE 11 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 AND 2030 (USD MILLION) 38

FIGURE 12 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 (%) 39

FIGURE 13 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 40

FIGURE 14 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 (%) 44

FIGURE 15 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 45

FIGURE 16 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 55

FIGURE 17 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 61

FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67

FIGURE 19 GLOBAL ARTIFICIAL INSEMINATION MARKET: COMPETITIVE LANDSCAPE 68

FIGURE 20 VITROLIFE AB: FINANCIAL OVERVIEW 70

FIGURE 21 VITROLIFE AB: SWOT ANALYSIS 72

FIGURE 22 GENEA LIMITED: SWOT ANALYSIS 74

FIGURE 23 RINOVUM WOMEN’S HEALTH, LLC: SWOT ANALYSIS 76

FIGURE 24 PRIDE ANGEL: SWOT ANALYSIS 78

FIGURE 25 HI-TECH SOLUTIONS: SWOT ANALYSIS 80

FIGURE 26 KITAZATO CORPORATION: SWOT ANALYSIS 82

FIGURE 27 FUJIFILM IRVINE SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT 83

FIGURE 28 FUJIFILM IRVINE SCIENTIFIC, INC.: SWOT ANALYSIS 84

FIGURE 29 ROCKET MEDICAL: FINANCIAL OVERVIEW SNAPSHOT 86

FIGURE 30 ROCKET MEDICAL: SWOT ANALYSIS 87